Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with Helicobacter pylori pIRES2-DsRed-Express- ureF DNA Vaccines
Archivum Immunologiae et Therapiae Experimentalis · 01.01.2024 · 72 (1)
DOI: 10.2478/aite-2024-0004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, online erschienen am 12.02.2024. Verfasst von Mahsa Afkhamipour und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran. Hauptthemen laut MEDLINE: Helicobacter pylori, Stomach Neoplasms, Vaccines, DNA, Helicobacter Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Most gastric cancers (GC) are thought to be caused by Helicobacter pylori ( H. pylori ) infections. However, there is mounting evidence that GC patients with positive H. pylori status have improved prognoses. The H. pylori -induced cellular immune reaction may inhibit cancer. In this study, BALB/c mice were immunized using recombinant plasmids that encode the ureF gene of H. pylori . Purified functional splenic CD3 + T lymphocytes are used to study the anticancer effects in vitro and in vivo . The immunological state of GC patients with ongoing H. pylori infection is mimicked by the H. pylori DNA vaccines, which cause a change in the reaction from Th1 to Th2. Human GC cells grow more slowly when stimulated CD3 + T lymphocytes are used as adoptive infusions because they reduce GC xenograft development in vivo . The more excellent ratios of infiltrating CD8 + /CD4 + T cells, the decreased invasion of regulatory FOXP3 + Treg lymphocytes, and the increased apoptosis brought on by Caspase9/Caspase-3 overexpression and Survivin downregulation may all contribute to the consequences. Our findings suggest that in people with advanced GC, H. pylori pIRES2-DsRed-Express- ureF DNA vaccines may have immunotherapeutic utility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology Research Center, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran.
- Biotechnology Research Center, East Tehran Branch, Islamic Azad University, Tehran, Iran.
Zitieren
APA
Afkhamipour, M., Kaviani, F., Dalali, S., Piri-Gharaghie, T., & Doosti, A. (2024). Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with Helicobacter pylori pIRES2-DsRed-Express- ureF DNA Vaccines. Archivum Immunologiae et Therapiae Experimentalis, 72(1). https://doi.org/10.2478/aite-2024-0004
Vancouver
Afkhamipour M, Kaviani F, Dalali S, Piri-Gharaghie T, Doosti A. Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with Helicobacter pylori pIRES2-DsRed-Express- ureF DNA Vaccines. Archivum Immunologiae et Therapiae Experimentalis. 2024;72(1). doi:10.2478/aite-2024-0004
BibTeX
@article{Afkhamipour2024,
author = {Afkhamipour, Mahsa and Kaviani, Fatemeh and Dalali, Samaneh and Piri-Gharaghie, Tohid and Doosti, Abbas},
title = {Potential Gastric Cancer Immunotherapy: Stimulating the Immune System with Helicobacter pylori pIRES2-DsRed-Express- ureF DNA Vaccines},
journal = {Archivum Immunologiae et Therapiae Experimentalis},
year = {2024},
volume = {72},
number = {1},
doi = {10.2478/aite-2024-0004}
}
EUVIMED